Lastly, our Healthcare business continues to perform well. Moving to liquidity on slide 6, we ended the second quarter with about $17 billion of industrial cash. In the third quarter, Industrial free cash flow was $650 million and we paid approximately $100 million in dividends. We received $1.6 billion of cash net of taxes and fees related to the Wabtec exit and $3 billion from Baker Hughes. The impact from the debt tender and other pay-downs was $5.5 billion and all other items were $100 million.